Phio Pharmaceuticals Corp (PHIO)

CIK 1533040 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Phio Pharmaceuticals Corp.

Recent SEC filings

FiledFormAccession number
Nov 5, 20268-K0001437749-26-035277
Nov 5, 202610-Q0001437749-26-035280
Oct 13, 20268-K0001437749-26-032505
Sep 30, 202640001683168-26-007499
Sep 29, 202640001683168-26-007481
Sep 29, 202640001683168-26-007483
Sep 29, 202640001683168-26-007482
Sep 28, 2026S-80001437749-26-031367
Sep 28, 20268-K0001437749-26-031337
Sep 25, 202640001683168-26-007432
Sep 23, 202640001683168-26-007321
Sep 16, 202640001683168-26-007192
Sep 15, 202640001683168-26-007158
Sep 15, 202640001683168-26-007159
Sep 14, 20268-K0001437749-26-030236
Aug 20, 202640001683168-26-006620
Aug 19, 202640001683168-26-006592
Aug 14, 2026ARS0001683168-26-006475
Aug 14, 2026DEF 14A0001437749-26-027997
Aug 14, 2026DEFA14A0001683168-26-006474
Aug 6, 202610-Q0001437749-26-026271
Aug 6, 20268-K0001437749-26-026275
Jul 30, 202630001683168-26-005842
Jul 21, 20268-K0001437749-26-023916
Jun 29, 202640001683168-26-005164